Aimee L. Davidson

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variants.

Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variants.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variants.

Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variants.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

Journal: BMC cancer

Published: March 09, 2026

Analysis of BRCA1, BRCA2 and PALB2 related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Analysis of BRCA1, BRCA2 and PALB2 related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Journal: medRxiv : the preprint server for health sciences

Published: June 26, 2025

BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Journal: American journal of human genetics

Published: May 15, 2025

The SeqSplice multiplexed minigene splicing assay for characterization and quantitation of variant-induced BRCA1 and BRCA2 splice isoforms.

The SeqSplice multiplexed minigene splicing assay for characterization and quantitation of variant-induced BRCA1 and BRCA2 splice isoforms.

Journal: Genome research

Published: May 07, 2024

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.

Journal: European journal of human genetics : EJHG

Published: May 01, 2024

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Journal: American journal of human genetics

Published: March 29, 2024

Regional-specific calibration enables application of computational evidence for clinical classification of 5' cis-regulatory variants in Mendelian disease.

Regional-specific calibration enables application of computational evidence for clinical classification of 5' cis-regulatory variants in Mendelian disease.

Journal: American journal of human genetics

Published: December 21, 2023

The splicing effect of variants at branchpoint elements in cancer genes.

The splicing effect of variants at branchpoint elements in cancer genes.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: January 07, 2023

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion.

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion.

Journal: Bioinformatics (Oxford, England)

Published: December 15, 2022

The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.

The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.

Journal: Genome medicine

Published: October 04, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026